Related Experiment Video
Updated: May 21, 2025

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Published on: December 11, 2020
Synthesis of an RBM39 Degrader That Downregulates CEP192 and Induces Disorganized Spindle Structures
Xilin Lyu1, Xiancheng Wang1,2, Dongze Lin3,4
1State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Rd., Shanghai 201203, China.
Abstract:
RBM39 is an essential component of the spliceosome, playing a critical role in maintaining mRNA integrity. Its depletion significantly exacerbates RNA splicing defects and demonstrates potent anticancer activity. To identify key effectors following RBM39 depletion, we employed a multiomics approach to directly compare two structurally distinct compounds, CB039 and Indisulam. Through proteomic analysis, RNA sequencing, and DepMap dependency assessment, CEP192 emerged as a crucial gene, exhibiting dependency in 96% of the 1,100 analyzed cancer cell lines. In eight cancer cell lines, treatment with both CB039 and Indisulam consistently induced CEP192 exon 42 skipping and reduced CEP192 protein levels. Mechanistically, either CB039 treatment or RNA interference-mediated CEP192 knockdown led to a significant increase in spindle disorganization, as well as chromosome condensation and failed segregation. In conclusion, our characterization of the downstream effects of RBM39 depletion provides novel insights into the therapeutic potential of RBM39 degraders.
Insights
Depleting RNA-binding protein 39 (RBM39) causes cancer cell death by disrupting splicing and affecting CEP192. This research reveals RBM39 degraders as promising anticancer agents.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genomics
Background:
- RNA-binding protein 39 (RBM39) is vital for mRNA splicing and integrity.
- RBM39 depletion exhibits significant anticancer activity by inducing splicing defects.
Purpose of the Study:
- To identify key downstream effectors of RBM39 depletion.
- To compare the effects of two distinct RBM39-targeting compounds, CB039 and Indisulam.
Main Methods:
- Multiomics approach including proteomics and RNA sequencing.
- DepMap dependency assessment across 1,100 cancer cell lines.
- Investigated CEP192 splicing and protein levels following compound treatment or RBM39 knockdown.
Main Results:
- CEP192 was identified as a crucial gene, essential in 96% of analyzed cancer cell lines.
- CB039 and Indisulam induced CEP192 exon 42 skipping and reduced CEP192 protein levels.
- CEP192 knockdown or CB039 treatment caused spindle disorganization and failed chromosome segregation.
Conclusions:
- RBM39 depletion disrupts CEP192 splicing and function, leading to mitotic defects.
- Characterization of RBM39's downstream effects highlights the therapeutic potential of RBM39 degraders in cancer treatment.
More Related Videos
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Spindle Assembly
In most cells, centrosomes are the primary microtubule nucleation centers. In the centrosome-mediated pathway, the G2-prophase transition triggers centrosome maturation and increased microtubule nucleation. Progressive nucleation results in a...
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Disassembly of Intermediate Filaments
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
The Mitotic Spindle
The bipolar configuration of the mitotic spindle facilitates chromosomal segregation, preparing the cell for division. One mechanism that ensures...
Anaphase A and B
Plus-end depolymerization releases tubulin heterodimers from the terminal region of the microtubule. As tubulin subunits are lost, the Ndc80 complexes detach...

